About Index Trending news
Lists
Pricing
MPM Capital

MPM Capital

MPM Capital

Investing in Healthcare Innovation

Elsewhere

Alexa global traffic share

Twitter followers

Investment profile

Geographical Focus
United States
Markets focus
Health Care Biotechnology
Stage Focus

Activity

Past year's investments
  • 3 rounds in the past year
  • $218,000,000 deployed in total
  • $72,666,667 avg per round
Latest rounds
  • Cullinan Oncology: Series A ($150M)
  • Repare Therapeutics: Venture capital (Series A) ($68M)
  • Semma Therapeutics: Venture capital (Undisclosed amount)
Total funding
$428.8M in 10 rounds from 25 investors
By MPM Capital
$58M Series D in Dec, 2012
Total funding
$277.8M in 8 rounds from 22 investors
By MPM Capital
$70M Series E in Feb, 2015
Total funding
$4.3M in 2 rounds from 4 investors
By MPM Capital
undisclosed deal in Mar, 2015
Total funding
$68M in 3 rounds from 14 investors
By MPM Capital
$20M Series C in Nov, 2011
Total funding
$172M in 2 rounds from 9 investors
By MPM Capital
$150M Series C in Sep, 2011
Total funding
$43.5M in 3 rounds from 7 investors
By MPM Capital
$32M Series B in Oct, 2009
Total funding
$231M in 3 rounds from 17 investors
By MPM Capital
$48M Series C in Mar, 2013
Total funding
$120.7M in 3 rounds from 9 investors
By MPM Capital
$42.7M Series B in Oct, 2003
Total funding
$107M in 3 rounds from 22 investors
By MPM Capital
$45M Series D in May, 2014
Total funding
$45M in 1 rounds from 11 investors
By MPM Capital
$45M Series C in May, 2006
Total funding
$149.1M in 2 rounds from 20 investors
By MPM Capital
$60.1M Series C in Jun, 2009
Total funding
$78.7M in 9 rounds from 41 investors
By MPM Capital
$21.5M Series E in Jan, 2010
Total funding
$20M in 1 rounds from 6 investors
By MPM Capital
$20M Series C in Oct, 2009
Total funding
$95.2M in 8 rounds from 18 investors
By MPM Capital
undisclosed deal in Jul, 2005
Total funding
$255M in 5 rounds from 29 investors
By MPM Capital
$40M Series E in Nov, 2013
Total funding
$102M in 3 rounds from 10 investors
By MPM Capital
$35M Series B in Apr, 2015
Exit Bioverativ, May 23, 2017
Total funding
$87.8M in 1 rounds from 7 investors
By MPM Capital
$87.8M Series D in Oct, 2009
Total funding
$40.5M in 3 rounds from 10 investors
By MPM Capital
$26.6M Series B in Aug, 2013
Total funding
$50M in 2 rounds from 15 investors
By MPM Capital
$10M Series C in Aug, 2016
Total funding
$43M in 1 rounds from 7 investors
By MPM Capital
$43M Series B in Mar, 2016
Total funding
$33.3M in 2 rounds from 5 investors
By MPM Capital
€30M Post-IPO equity in Jun, 2016
Total funding
$45M in 1 rounds from 6 investors
By MPM Capital
$45M Series B in Jun, 2016
Total funding
$57M in 1 rounds from 7 investors
By MPM Capital
$57M Series A in Jul, 2016
Total funding
$5M in 2 rounds from 6 investors
By MPM Capital
undisclosed deal in Mar, 2017
Total funding
$44.5M in 1 rounds from 2 investors
By MPM Capital
$44.5M Series A in Dec, 2016
Total funding
$68M in 1 rounds from 5 investors
By MPM Capital
$68M Series A in Jun, 2017
Total funding
$150M in 1 rounds from 2 investors
By MPM Capital
$150M Series A in Oct, 2017

Want to see the complete list?
Go Pro!